[Federal Register: May 29, 2003 (Volume 68, Number 103)]
[Notices]               
[Page 32089]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29my03-147]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to section 1301.33(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on June 10, 2002, Organix, Inc., 
240 Salem Street, Woburn, MA 01810, made application by renewal to the 
Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic class of Cocaine (9041), a Schedule II 
controlled substance.
    The firm plans to synthesize a controlled substance derivative from 
a non-controlled substance; the derivative will be sold to the firm's 
customer for research purposes.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCD) and must be filed no later than July 28, 2003.

    Dated: May 7, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-13310 Filed 5-28-03; 8:45 am]

BILLING CODE 4410-09-M